Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 414

1.

Reduced Function of the Glutathione S-Transferase S1 Suppresses Behavioral Hyperexcitability in Drosophila Expressing Mutant Voltage-Gated Sodium Channels.

Chen HL, Kasuya J, Lansdon P, Kaas G, Tang H, Sodders M, Kitamoto T.

G3 (Bethesda). 2020 Feb 13. pii: g3.401025.2019. doi: 10.1534/g3.119.401025. [Epub ahead of print]

2.

Co-existence of PrPD types 1 and 2 in sporadic Creutzfeldt-Jakob disease of the VV subgroup: phenotypic and prion protein characteristics.

Cali I, Puoti G, Smucny J, Curtiss PM, Cracco L, Kitamoto T, Occhipinti R, Cohen ML, Appleby BS, Gambetti P.

Sci Rep. 2020 Jan 30;10(1):1503. doi: 10.1038/s41598-020-58446-0.

3.

Clinical characteristics of jellyfish stings in Japan.

Hifumi T, Fukuchi Y, Otani N, Kondo Y, Kitamoto T, Kobayashi K, Nakaya N, Tomioka J.

Acute Med Surg. 2019 Nov 25;7(1):e469. doi: 10.1002/ams2.469. eCollection 2020 Jan-Dec.

4.

Significance of DopEcR, a G-protein coupled dopamine/ecdysteroid receptor, in physiological and behavioral response to stressors.

Petruccelli E, Lark A, Mrkvicka JA, Kitamoto T.

J Neurogenet. 2020 Jan 20:1-14. doi: 10.1080/01677063.2019.1710144. [Epub ahead of print]

PMID:
31955616
5.

Environmental Light Is Required for Maintenance of Long-Term Memory in Drosophila.

Inami S, Sato S, Kondo S, Tanimoto H, Kitamoto T, Sakai T.

J Neurosci. 2020 Feb 12;40(7):1427-1439. doi: 10.1523/JNEUROSCI.1282-19.2019. Epub 2020 Jan 13.

PMID:
31932417
6.

A case of M232R genetic Creutzfeldt-Jakob disease with Lewy bodies.

Akagi A, Iwasaki Y, Hashimoto R, Aiba I, Inukai A, Mimuro M, Riku Y, Miyahara H, Kitamoto T, Yoshida M.

J Neurol Sci. 2020 Feb 15;409:116605. doi: 10.1016/j.jns.2019.116605. Epub 2019 Nov 28. No abstract available.

PMID:
31811987
7.

Eliminating transmissibility of bovine spongiform encephalopathy by dry-heat treatment.

Matsuura Y, Ishikawa Y, Murayama Y, Yokoyama T, Somerville RA, Kitamoto T, Mohri S.

J Gen Virol. 2020 Jan;101(1):136-142. doi: 10.1099/jgv.0.001335.

PMID:
31718739
8.

Correlating diffusion-weighted MRI intensity with type 2 pathology in mixed MM-type sporadic Creutzfeldt-Jakob disease.

Ikeda T, Iwasaki Y, Sakurai K, Akagi A, Riku Y, Mimuro M, Miyahara H, Kitamoto T, Matsukawa N, Yoshida M.

J Neurol Sci. 2020 Jan 15;408:116515. doi: 10.1016/j.jns.2019.116515. Epub 2019 Oct 22.

PMID:
31675505
9.

Autopsy case of MV2K-type sporadic Creutzfeldt-Jakob disease with spongiform changes of the cerebral cortex.

Iwasaki Y, Hiraga K, Ito S, Ando T, Akagi A, Riku Y, Mimuro M, Miyahara H, Kobayashi A, Kitamoto T, Yoshida M.

Neuropathology. 2019 Dec;39(6):452-460. doi: 10.1111/neup.12595. Epub 2019 Sep 12.

PMID:
31515858
10.

Marchiafava-Bignami disease with haemophagocytic lymphohistiocytosis as a postoperative complication of cardiac surgery.

Takei K, Motoyoshi N, Sakamoto K, Kitamoto T.

BMJ Case Rep. 2019 Aug 26;12(8). pii: e230368. doi: 10.1136/bcr-2019-230368.

PMID:
31451466
11.

Clinicopathological findings of an MM2-cortical-type sporadic Creutzfeldt-Jakob disease patient with cortical blindness during a course of glaucoma and age-related macular degeneration.

Hayashi Y, Iwasaki Y, Waza M, Shibata H, Akagi A, Kimura A, Inuzuka T, Satoh K, Kitamoto T, Yoshida M, Shimohata T.

Prion. 2019 Jan;13(1):124-131. doi: 10.1080/19336896.2019.1631680.

12.

Age at onset in genetic prion disease and the design of preventive clinical trials.

Minikel EV, Vallabh SM, Orseth MC, Brandel JP, Haïk S, Laplanche JL, Zerr I, Parchi P, Capellari S, Safar J, Kenny J, Fong JC, Takada LT, Ponto C, Hermann P, Knipper T, Stehmann C, Kitamoto T, Ae R, Hamaguchi T, Sanjo N, Tsukamoto T, Mizusawa H, Collins SJ, Chiesa R, Roiter I, de Pedro-Cuesta J, Calero M, Geschwind MD, Yamada M, Nakamura Y, Mead S.

Neurology. 2019 Jul 9;93(2):e125-e134. doi: 10.1212/WNL.0000000000007745. Epub 2019 Jun 6.

PMID:
31171647
13.

Milk-whey diet substantially suppresses seizure-like phenotypes of paraShu, a Drosophila voltage-gated sodium channel mutant.

Kasuya J, Iyengar A, Chen HL, Lansdon P, Wu CF, Kitamoto T.

J Neurogenet. 2019 Sep;33(3):164-178. doi: 10.1080/01677063.2019.1597082. Epub 2019 May 16.

PMID:
31096839
14.

Autopsied case of sporadic Creutzfeldt-Jakob disease classified as MM1+2C-type.

Iwasaki Y, Kato H, Ando T, Akagi A, Mimuro M, Miyahara H, Kobayashi A, Kitamoto T, Yoshida M.

Neuropathology. 2019 Jun;39(3):240-247. doi: 10.1111/neup.12557. Epub 2019 May 7.

PMID:
31062411
15.

Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open-label, blinded-endpoint, randomized controlled study (PRIME-V study).

Koshizaka M, Ishikawa K, Ishibashi R, Maezawa Y, Sakamoto K, Uchida D, Nakamura S, Yamaga M, Yokoh H, Kobayashi A, Onishi S, Kobayashi K, Ogino J, Hashimoto N, Tokuyama H, Shimada F, Ohara E, Ishikawa T, Shoji M, Ide S, Ide K, Baba Y, Hattori A, Kitamoto T, Horikoshi T, Shimofusa R, Takahashi S, Nagashima K, Sato Y, Takemoto M, Newby LK, Yokote K; PRIME-V Study Group.

Diabetes Obes Metab. 2019 Aug;21(8):1990-1995. doi: 10.1111/dom.13750. Epub 2019 May 8.

16.

The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins.

Rossi M, Kai H, Baiardi S, Bartoletti-Stella A, Carlà B, Zenesini C, Capellari S, Kitamoto T, Parchi P.

Acta Neuropathol Commun. 2019 Apr 8;7(1):53. doi: 10.1186/s40478-019-0706-6.

17.

Identification of Insulin-Responsive Transcription Factors That Regulate Glucose Production by Hepatocytes.

Wang L, Liu Q, Kitamoto T, Hou J, Qin J, Accili D.

Diabetes. 2019 Jun;68(6):1156-1167. doi: 10.2337/db18-1236. Epub 2019 Apr 1.

18.

A Novel Combination of Prion Strain Co-Occurrence in Patients with Sporadic Creutzfeldt-Jakob Disease.

Kobayashi A, Iwasaki Y, Takao M, Saito Y, Iwaki T, Qi Z, Torimoto R, Shimazaki T, Munesue Y, Isoda N, Sawa H, Aoshima K, Kimura T, Kondo H, Mohri S, Kitamoto T.

Am J Pathol. 2019 Jun;189(6):1276-1283. doi: 10.1016/j.ajpath.2019.02.012. Epub 2019 Mar 27.

PMID:
30926338
19.

Correction to: In Vitro Seeding Activity of Glycoform-Deficient Prions from Variably Protease-Sensitive Prionopathy and Familial CJD Associated with PrPV180I Mutation.

Wang Z, Yuan J, Shen P, Abskharon R, Lang Y, Dang J, Adornato A, Xu L, Chen J, Feng J, Moudjou M, Kitamoto T, Lee HG, Kim YS, Langeveld J, Appleby B, Ma J, Kong Q, Petersen RB, Zou WQ, Cui L.

Mol Neurobiol. 2019 Aug;56(8):5470. doi: 10.1007/s12035-019-1508-3.

20.

Sensitive quantification of BB-22 and its metabolite BB-22 3-carboxyindole, and characterization of new metabolites in authentic urine and/or serum specimens obtained from three individuals by LC-QTRAP-MS/MS and high-resolution LC-Orbitrap-MS/MS.

Minakata K, Hasegawa K, Nozawa H, Yamagishi I, Saitoh T, Yoshino A, Suzuki M, Kitamoto T, Suzuki O, Watanabe K.

Forensic Toxicol. 2019;37(1):164-173. doi: 10.1007/s11419-018-0448-3. Epub 2018 Oct 16.

21.

In Vitro Seeding Activity of Glycoform-Deficient Prions from Variably Protease-Sensitive Prionopathy and Familial CJD Associated with PrPV180I Mutation.

Wang Z, Yuan J, Shen P, Abskharon R, Lang Y, Dang J, Adornato A, Xu L, Chen J, Feng J, Moudjou M, Kitamoto T, Lee HG, Kim YS, Langeveld J, Appleby B, Ma J, Kong Q, Petersen RB, Zou WQ, Cui L.

Mol Neurobiol. 2019 Aug;56(8):5456-5469. doi: 10.1007/s12035-018-1459-0. Epub 2019 Jan 5. Erratum in: Mol Neurobiol. 2019 Feb 1;:.

22.

Ganglioside Synthase Knockout Reduces Prion Disease Incubation Time in Mouse Models.

Kobayashi A, Qi Z, Shimazaki T, Munesue Y, Miyamoto T, Isoda N, Sawa H, Aoshima K, Kimura T, Mohri S, Kitamoto T, Yamashita T, Miyoshi I.

Am J Pathol. 2019 Mar;189(3):677-686. doi: 10.1016/j.ajpath.2018.11.009. Epub 2018 Dec 13.

23.

Intermolecular crosslinking of abnormal prion protein is efficiently induced by a primuline-sensitized photoreaction.

Teruya K, Nishizawa K, Oguma A, Sakasegawa Y, Kitamoto T, Doh-Ura K.

Biochim Biophys Acta Gen Subj. 2019 Feb;1863(2):384-394. doi: 10.1016/j.bbagen.2018.11.008. Epub 2018 Nov 14.

PMID:
30447252
24.

An autopsied case of MM1-type sporadic Creutzfeldt-Jakob disease with pathology of Wernicke encephalopathy.

Iwasaki Y, Hashimoto R, Saito Y, Aiba I, Inukai A, Akagi A, Mimuro M, Miyahara H, Kitamoto T, Yoshida M.

Prion. 2019 Jan;13(1):13-20. doi: 10.1080/19336896.2018.1545525. Epub 2018 Nov 14.

25.

Specific amyloid-β42 deposition in the brain of a Gerstmann-Sträussler-Scheinker disease patient with a P105L mutation on the prion protein gene.

Furukawa F, Sanjo N, Kobayashi A, Hamaguchi T, Yamada M, Kitamoto T, Mizusawa H, Yokota T.

Prion. 2018;12(5-6):315-319. doi: 10.1080/19336896.2018.1541689. Epub 2018 Nov 13.

26.

[Genetic Creutzfeldt-Jakob disease with a glutamate-to-lysine substitution at codon 219 (E219K) in the presence of the E200K mutation presenting with rapid progressive dementia following slowly progressive clinical course].

Takayanagi M, Suzuki K, Nakamura T, Hirata K, Satoh K, Kitamoto T.

Rinsho Shinkeigaku. 2018 Nov 28;58(11):682-687. doi: 10.5692/clinicalneurol.cn-001206. Epub 2018 Oct 27. Japanese.

PMID:
30369528
27.

Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma.

Yamazaki Y, Omata K, Tezuka Y, Ono Y, Morimoto R, Adachi Y, Ise K, Nakamura Y, Gomez-Sanchez CE, Shibahara Y, Kitamoto T, Nishikawa T, Ito S, Satoh F, Sasano H.

Hypertension. 2018 Sep;72(3):632-640. doi: 10.1161/HYPERTENSIONAHA.118.10907.

28.

A case of intoxication with a mixture of synthetic cannabinoids EAM-2201, AB-PINACA and AB-FUBINACA, and a synthetic cathinone α-PVP.

Yamagishi I, Minakata K, Nozawa H, Hasegawa K, Suzuki M, Kitamoto T, Suzuki O, Watanabe K.

Leg Med (Tokyo). 2018 Nov;35:44-49. doi: 10.1016/j.legalmed.2018.08.004. Epub 2018 Aug 6.

PMID:
30268690
29.

An autopsy report of three kindred in a Gerstmann-Sträussler-Scheinker disease P105L family with a special reference to prion protein, tau, and beta-amyloid.

Ishizawa K, Mitsufuji T, Shioda K, Kobayashi A, Komori T, Nakazato Y, Kitamoto T, Araki N, Yamamoto T, Sasaki A.

Brain Behav. 2018 Oct;8(10):e01117. doi: 10.1002/brb3.1117. Epub 2018 Sep 21.

30.

Autopsy case of V180I genetic Creutzfeldt-Jakob disease presenting with early disease pathology.

Iwasaki Y, Kato H, Ando T, Akagi A, Mimuro M, Miyahara H, Kitamoto T, Yoshida M.

Neuropathology. 2018 Dec;38(6):638-645. doi: 10.1111/neup.12516. Epub 2018 Sep 14.

PMID:
30216556
31.

Identification of differentially methylated region (DMR) networks associated with progression of nonalcoholic fatty liver disease.

Hotta K, Kitamoto A, Kitamoto T, Ogawa Y, Honda Y, Kessoku T, Yoneda M, Imajo K, Tomeno W, Saito S, Nakajima A.

Sci Rep. 2018 Sep 11;8(1):13567. doi: 10.1038/s41598-018-31886-5.

32.

PrPres deposition in the retina is a common finding of sporadic, familial and iatrogenic Creutzfeldt-Jakob diseases (CJD).

Takao M, Kimura H, Kitamoto T, Mihara B.

Acta Neuropathol Commun. 2018 Aug 10;6(1):78. doi: 10.1186/s40478-018-0582-5. No abstract available.

33.

Autopsied case of non-plaque-type dura mater graft-associated Creutzfeldt-Jakob disease presenting with extensive amyloid-β deposition.

Iwasaki Y, Imamura K, Iwai K, Kobayashi Y, Akagi A, Mimuro M, Miyahara H, Kitamoto T, Yoshida M.

Neuropathology. 2018 Oct;38(5):549-556. doi: 10.1111/neup.12503. Epub 2018 Aug 6.

PMID:
30084170
34.

A domain responsible for spontaneous conversion of bank vole prion protein.

Kobayashi A, Matsuura Y, Takeuchi A, Yamada M, Miyoshi I, Mohri S, Kitamoto T.

Brain Pathol. 2019 Mar;29(2):155-163. doi: 10.1111/bpa.12638. Epub 2018 Oct 29.

PMID:
30051525
35.

Aldosterone Suppression by Dexamethasone in Patients With KCNJ5-Mutated Aldosterone-Producing Adenoma.

Inoue K, Yamazaki Y, Kitamoto T, Hirose R, Saito J, Omura M, Sasano H, Nishikawa T.

J Clin Endocrinol Metab. 2018 Sep 1;103(9):3477-3485. doi: 10.1210/jc.2018-00738.

PMID:
30020487
36.

Neuroimaging-pathological correlations of [18F]THK5351 PET in progressive supranuclear palsy.

Ishiki A, Harada R, Kai H, Sato N, Totsune T, Tomita N, Watanuki S, Hiraoka K, Ishikawa Y, Funaki Y, Iwata R, Furumoto S, Tashiro M, Sasano H, Kitamoto T, Kudo Y, Yanai K, Furukawa K, Okamura N, Arai H.

Acta Neuropathol Commun. 2018 Jun 29;6(1):53. doi: 10.1186/s40478-018-0556-7.

37.

Immune-mediated acquired lecithin-cholesterol acyltransferase deficiency: A case report and literature review.

Ishibashi R, Takemoto M, Tsurutani Y, Kuroda M, Ogawa M, Wakabayashi H, Uesugi N, Nagata M, Imai N, Hattori A, Sakamoto K, Kitamoto T, Maezawa Y, Narita I, Hiroi S, Furuta A, Miida T, Yokote K.

J Clin Lipidol. 2018 Jul - Aug;12(4):888-897.e2. doi: 10.1016/j.jacl.2018.05.002. Epub 2018 May 15.

PMID:
29937398
38.

Iatrogenic Creutzfeldt-Jakob disease.

Kobayashi A, Kitamoto T, Mizusawa H.

Handb Clin Neurol. 2018;153:207-218. doi: 10.1016/B978-0-444-63945-5.00012-X.

PMID:
29887137
39.

Creutzfeldt-Jakob disease with Alzheimer pathology, presenting with status epilepticus following repeated partial seizures: a case report and literature review.

Miyake K, Hara T, Oshima E, Kawada K, Ishizu H, Yamauchi Y, Satoh K, Kitamoto T, Takenoshita S, Terada S, Yamada N.

BMC Neurol. 2018 Apr 25;18(1):54. doi: 10.1186/s12883-018-1055-y. Review.

40.

Biochemical features of genetic Creutzfeldt-Jakob disease with valine-to-isoleucine substitution at codon 180 on the prion protein gene.

Ito Y, Sanjo N, Hizume M, Kobayashi A, Ohgami T, Satoh K, Hamaguchi T, Yamada M, Kitamoto T, Mizusawa H, Yokota T.

Biochem Biophys Res Commun. 2018 Feb 19;496(4):1055-1061. doi: 10.1016/j.bbrc.2018.01.119. Epub 2018 Jan 31.

PMID:
29382530
41.

Development of a quick bioassay for the evaluation of transmission properties of acquired prion diseases.

Munesue Y, Shimazaki T, Qi Z, Isoda N, Sawa H, Aoshima K, Kimura T, Mohri S, Kitamoto T, Kobayashi A.

Neurosci Lett. 2018 Mar 6;668:43-47. doi: 10.1016/j.neulet.2018.01.014. Epub 2018 Jan 9.

PMID:
29329906
42.

Distinct roles of systemic and local actions of insulin on pancreatic β-cells.

Kitamoto T, Sakurai K, Lee EY, Yokote K, Accili D, Miki T.

Metabolism. 2018 May;82:100-110. doi: 10.1016/j.metabol.2017.12.017. Epub 2018 Jan 7.

PMID:
29320716
43.

Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study.

Cali I, Cohen ML, Haik S, Parchi P, Giaccone G, Collins SJ, Kofskey D, Wang H, McLean CA, Brandel JP, Privat N, Sazdovitch V, Duyckaerts C, Kitamoto T, Belay ED, Maddox RA, Tagliavini F, Pocchiari M, Leschek E, Appleby BS, Safar JG, Schonberger LB, Gambetti P.

Acta Neuropathol Commun. 2018 Jan 8;6(1):5. doi: 10.1186/s40478-017-0503-z.

44.

Pathological progression of genetic Creutzfeldt-Jakob disease with a PrP V180I mutation.

Akagi A, Iwasaki Y, Mimuro M, Kitamoto T, Yamada M, Yoshida M.

Prion. 2018 Jan 2;12(1):54-62. doi: 10.1080/19336896.2017.1414130. Epub 2018 Jan 31.

45.

Area-Specific Regulation of Quiescent Neural Stem Cells by Notch3 in the Adult Mouse Subependymal Zone.

Kawai H, Kawaguchi D, Kuebrich BD, Kitamoto T, Yamaguchi M, Gotoh Y, Furutachi S.

J Neurosci. 2017 Dec 6;37(49):11867-11880. doi: 10.1523/JNEUROSCI.0001-17.2017. Epub 2017 Nov 3.

46.

Evolutionarily Conserved Roles for Blood-Brain Barrier Xenobiotic Transporters in Endogenous Steroid Partitioning and Behavior.

Hindle SJ, Munji RN, Dolghih E, Gaskins G, Orng S, Ishimoto H, Soung A, DeSalvo M, Kitamoto T, Keiser MJ, Jacobson MP, Daneman R, Bainton RJ.

Cell Rep. 2017 Oct 31;21(5):1304-1316. doi: 10.1016/j.celrep.2017.10.026.

47.

Identification of the genomic region under epigenetic regulation during non-alcoholic fatty liver disease progression.

Hotta K, Kitamoto T, Kitamoto A, Ogawa Y, Honda Y, Kessoku T, Yoneda M, Imajo K, Tomeno W, Saito S, Nakajima A.

Hepatol Res. 2018 Feb;48(3):E320-E334. doi: 10.1111/hepr.12992. Epub 2017 Nov 17.

PMID:
29059699
48.

KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma.

Kitamoto T, Omura M, Suematsu S, Saito J, Nishikawa T.

J Hypertens. 2018 Mar;36(3):619-627. doi: 10.1097/HJH.0000000000001578.

PMID:
29016532
49.

Clinical findings of a probable case of MM2-cortical-type sporadic Creutzfeldt-Jakob disease with antibodies to anti-N-terminus of α-enolase.

Hayashi Y, Yamada M, Kimura A, Asano T, Satoh K, Kitamoto T, Yoneda M, Inuzuka T.

Prion. 2017 Nov 2;11(6):454-464. doi: 10.1080/19336896.2017.1377876. Epub 2017 Oct 30.

50.

Correlations of 18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease.

Harada R, Ishiki A, Kai H, Sato N, Furukawa K, Furumoto S, Tago T, Tomita N, Watanuki S, Hiraoka K, Ishikawa Y, Funaki Y, Nakamura T, Yoshikawa T, Iwata R, Tashiro M, Sasano H, Kitamoto T, Yanai K, Arai H, Kudo Y, Okamura N.

J Nucl Med. 2018 Apr;59(4):671-674. doi: 10.2967/jnumed.117.197426. Epub 2017 Sep 1.

Supplemental Content

Loading ...
Support Center